HIV/AIDS Flashcards
most predominant type of HIV in US
HIV-1
most predominant type of HIV in developing world
HIV-2
what does it mean to say HIV is retrovirus?
RNA virus that uses our own molecular biochemistry to produce copies
constantly mutating so vaccine development is difficult
how is HIV transmitted?
- Sexual contact
- Needle sticks
- Vertically (mother to baby)
- Blood transfusion
risk of sexual transmission of HIV is increased if
presence of inflammatory/ulcerative lesions of mucosa
trauma
uncircumcised partner
dominant mode of HIV transmission worldwide?
heterosexual intercourse
risk of vertical transmission is increased with
vaginal delivery
mothers with high viral load
mothers who breast fed
how is risk of vertical transmission decreased?
antiretroviral treatment to mother during pregnancy and immediately after birth
how is risk of IV drug use decreased
post exposure prophylaxis
HIV race in US
disproportionally affects African Americans and to lesser extent Hispanics
this is a socioeconomic issue
latino MSM are only grp increasing
HIV in US - age
mc acquired by young adult (20-24)
other HIV stats (just review)
1 in 8 are unaware of their positive status
south has greatest numbers in US
numbers of people w/HIV decreases with antiretroviral therapy - only 41% of people have access
HIV pathophysiology
- entry into cells mediated primary by viral binding to CD4
- inside, reverse transcriptase converts RNA genome into DNA
- viral genome is inserted into our genome (CD4= virus factory)
- cell lysis releases millions of HIV visions into blood stream
- Macrophages disseminate virus to other organs
Depleting CD4 cells therefore affects immunity: (humoral and cellular)
- Cellular - CD4 T cell destruction, disorganized NK and CD8 activity
- Humoral - B lymphocyte dysfunction
natural progression of HIV (5 steps)
- 4-11 days of exposure, rapid viral replication
- 2-6 weeks = flu like illness
- brisk immune response ensues and T lymphocyte population rebounds, high viral load decreases rapidly
- 6-12 months later, viral load stabilizes (viral set point) and is latent
- infectious but not symptomatic - eventually CD4 levels decline and viral load rises, causing immune dysfunction
Acute Retroviral Syndrome
2-6 wks following exposure
lasts 7-21 days
marks process of seroconversion (decreasing CD4 and increasing HIV)
acute retroviral syndrome symptoms
HA, fatigue, myalgia, acute/aseptic meningitis
pts have low glucose and high protein
missed opportunity to start therapy and change behavior
asymptomatic phase
pt feels fine but suffers from persistent lymphadenopathy
early, transient thrombocytopenia
early symptomatic phase
pts have increased susceptiability to pulmonary infection and bacteremia (H. flu, tb, pneumo pneumonia) AND mucocutanous disease
common mucocutaneous lesions in early HIV states
shingles/zoster
thrust
HSV
oral hairy leukoplakia
late symptomatic phase
high risk of developing opportunistic infection at CD4 counts < 200
its are started on prophylaxis
testing for HIV - who gets tested?
everyone should be tested at least once in life
high risk and persons in healthcare be tested annually
pregnant women (1st and 3rd trimester)
false negative HIV tests
possible for any test between when there exposure and Ab detection (home tests)
ABs take 3-12 weeks to develop
office tests used in HIV
ELISA confirmed by Western blot
ELISA HIV abs tests
HIV ab in saliva and p24 hg
initial management of HIV
excellent history with ROS
complete physical exam
lab testing of initial management HIV (8)
- CBC + Dif, chem, LFT, TSH, lipid, b12
- PPD (5+ m positive)
- . toxoplasmosis
- RPR (syphilis)
- CMV serology
- Gonococcal/Chlamydia NAAT
- viral hep screen
- baseline HIV genotype
category A
asymptomatic HIV infection w/o history of symptoms or AIDS defining conditions
category B
HIV infection w/symptoms directly attributed to HIV infection or complicated by HIV infection
category C
HIV infection with AIDS defining opportunistic infection
principals of ART (3)
- suppressive (not curative) so it is lifelong
- ALL ART is associated with significant toxicity
- risk of developing resistance increases if you don’t adhere exactly to treatment
ART should only be initiated in patients:
- when benefit is > risk
2. pt will adhere to regemine
when is ART started? why?
advocated for patient at time of diagnosis (regardless of CD4 count)
this is to aid in CD4 recovery (stopping viral replication) and decrease transmission
viral load can go to less than detectible levels
goal of ART
make virus undetectable in blood